Target intelligence / Profile preview

Beta-lactamase (Class A and Class C) (N/A)

Target
N/A
Molecular classification
Enzyme, Hydrolase, Serine Beta-Lactamase
01

Overview

Beta-lactamases are enzymes produced by bacteria that confer resistance to beta-lactam antibiotics by hydrolyzing the beta-lactam ring, rendering these drugs ineffective. Class A and Class C beta-lactamases are serine-based enzymes that hydrolyze penicillins, cephalosporins, monobactams and carbapenems (to varying degrees depending on the enzyme type). Class A beta-lactamases are often inhibited by clavulanic acid, tazobactam, and sulbactam, whereas class C beta-lactamases are generally not inhibited by these classic inhibitors, but avibactam may inhibit some AmpC enzymes. The presence of these enzymes complicates treatment choices for serious infections caused by resistant Gram-negative bacteria.

Other names
Class A Beta-LactamaseClass C Beta-LactamaseAmpC Beta-Lactamase
02

Mechanism of action

Hydrolyzes the beta-lactam ring of beta-lactam antibiotics, preventing them from inhibiting bacterial cell wall synthesis.

03

Biological functions

Antibiotic resistanceHydrolysis of beta-lactam ringInactivation of beta-lactam antibiotics
04

Disease associations

InfectionAntibiotic resistanceTreatment failure
05

Safety considerations

Antibiotic resistanceTreatment failureSpread of resistant bacteriaLimited treatment options for infections caused by beta-lactamase producing organisms
06

Interacting drugs

Penicillins

7 more in the full profile.

07

Biomarkers

Presence of beta-lactamase genes (e.g., TEM, SHV, CTX-M, AmpC)Detection of beta-lactamase activity in bacterial isolates

Beyond the preview

Go deeper on Beta-lactamase (Class A and Class C) (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-lactamase (Class A and Class C) (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call